title: Measurement of apolipoprotein E and amyloid β clearance rates in the mouse brain using bolus stable isotope labeling.
abstract: BACKGROUND
  Abnormal proteostasis due to alterations in protein turnover has been postulated to play a central role in several neurodegenerative diseases. Therefore, the development of techniques to quantify protein turnover in the brain is critical for understanding the pathogenic mechanisms of these diseases. We have developed a bolus stable isotope-labeling kinetics (SILK) technique coupled with multiple reaction monitoring mass spectrometry to measure the clearance of proteins in the mouse brain.
  
  
  RESULTS
  Cohorts of mice were pulse labeled with 13C6-leucine and the brains were isolated after pre-determined time points. The extent of label incorporation was measured over time using mass spectrometry to measure the ratio of labeled to unlabeled apolipoprotein E (apoE) and amyloid β (Aβ). The fractional clearance rate (FCR) was then calculated by analyzing the time course of disappearance for the labeled protein species. To validate the technique, apoE clearance was measured in mice that overexpress the low-density lipoprotein receptor (LDLR). The FCR in these mice was 2.7-fold faster than wild-type mice. To demonstrate the potential of this technique for understanding the pathogenesis of neurodegenerative disease, we applied our SILK technique to determine the effect of ATP binding cassette A1 (ABCA1) on both apoE and Aβ clearance. ABCA1 had previously been shown to regulate both the amount of apoE in the brain, along with the extent of Aβ deposition, and represents a potential molecular target for lowering brain amyloid levels in Alzheimer's disease patients. The FCR of apoE was increased by 1.9- and 1.5-fold in mice that either lacked or overexpressed ABCA1, respectively. However, ABCA1 had no effect on the FCR of Aβ, suggesting that ABCA1 does not regulate Aβ metabolism in the brain.
  
  
  CONCLUSIONS
  Our SILK strategy represents a straightforward, cost-effective, and efficient method to measure the clearance of proteins in the mouse brain. We expect that this technique will be applicable to the study of protein dynamics in the pathogenesis of several neurodegenerative diseases, and could aid in the evaluation of novel therapeutic agents.
authors.affiliation: Department of Neurology, Saint Louis, Missouri 63110, USA.
authors.forename: Jacob M
authors.initials: JM
authors.lastname: Basak
authors.forename: Jungsu
authors.initials: J
authors.lastname: Kim
authors.forename: Yuriy
authors.initials: Y
authors.lastname: Pyatkivskyy
authors.forename: Kristin R
authors.initials: KR
authors.lastname: Wildsmith
authors.forename: Hong
authors.initials: H
authors.lastname: Jiang
authors.forename: Maia
authors.initials: M
authors.lastname: Parsadanian
authors.forename: Bruce W
authors.initials: BW
authors.lastname: Patterson
authors.forename: Randall J
authors.initials: RJ
authors.lastname: Bateman
authors.forename: David M
authors.initials: DM
authors.lastname: Holtzman
mesh_terms: D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D001057:Apolipoproteins E / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D002247:Carbon Isotopes; D002853:Chromatography, Liquid / Q000379:methods; D047468:Immunoprecipitation; D007553:Isotope Labeling; D013058:Mass Spectrometry / Q000379:methods; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011849:Radioactive Tracers
chemical_list: D016229:Amyloid beta-Peptides; D001057:Apolipoproteins E; D002247:Carbon Isotopes; D011849:Radioactive Tracers